REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $689,454 | -3.0% | 6,762 | -13.5% | 0.01% | 0.0% |
| Q1 2023 | $710,449 | +146.9% | 7,814 | +3.2% | 0.01% | +100.0% |
| Q4 2022 | $287,774 | +30.8% | 7,575 | +4.5% | 0.00% | +50.0% |
| Q2 2022 | $220,000 | -7.2% | 7,250 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | -67.6% | 7,231 | -0.4% | 0.00% | -66.7% |
| Q3 2021 | $731,000 | -28.1% | 7,263 | +1.2% | 0.01% | -25.0% |
| Q2 2021 | $1,016,000 | +42.9% | 7,179 | +0.6% | 0.01% | +33.3% |
| Q1 2021 | $711,000 | -18.3% | 7,135 | +1.3% | 0.01% | -25.0% |
| Q4 2020 | $870,000 | +23.6% | 7,040 | -2.5% | 0.01% | +14.3% |
| Q3 2020 | $704,000 | -15.7% | 7,224 | +34.9% | 0.01% | -41.7% |
| Q2 2020 | $835,000 | +13.5% | 5,355 | +5.0% | 0.01% | -7.7% |
| Q1 2020 | $736,000 | – | 5,102 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |